PRICE T ROWE ASSOCIATES INC /MD/

Position in TRVI — Trevi Therapeutics, Inc.

CIK 80255 BALTIMORE, MD

Position in TRVI

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$771,906

+$142,489 QoQ

Shares Held

64,703

+28.7% QoQ

Ownership

0.046%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2024

9 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

PRICE T ROWE ASSOCIATES INC /MD/ holds $13,950,986,356 across 255 Biotechnology names. TRVI ranks #163 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ARGX	Argenx SE	3,374,955	$2,464,560,888
2	REGN	Regeneron Pharmaceuticals, Inc.	2,177,527	$1,682,444,460
3	VRTX	Vertex Pharmaceuticals Inc / Ma	1,760,122	$785,964,877
4	INSM	INSMED Inc	3,092,807	$505,735,799
5	KYMR	Kymera Therapeutics, Inc.	6,060,847	$504,807,946
6	ALNY	Alnylam Pharmaceuticals, Inc.	1,432,748	$474,053,330
7	RVMD	Revolution Medicines, Inc.	3,232,213	$314,332,713
8	SRRK	Scholar Rock Holding Corp	6,206,618	$305,117,340

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$771,906	64,703	+28.7%	Shares	Defined	2026-05-15
2025-12-31	$629,417	50,273	+7.3%	Shares	Defined	2026-02-17
2025-09-30	$428,759	46,859	+21.5%	Shares	Defined	2025-11-14
2025-06-30	$210,879	38,552	+19.9%	Shares	Defined	2025-08-14
2025-03-31	$202,298	32,162	+27.8%	Shares	Defined	2025-05-14
2024-12-31	$103,683	25,166	+32.1%	Shares	Defined	2025-02-14
2024-09-30	$63,616	19,047	0.0%	Shares	Defined	2024-11-14
2024-06-30	$56,760	19,047	+40.5%	Shares	Defined	2024-08-14
2024-03-31	$46,785	13,561	—	Shares	Defined	2024-05-15
No filing history on record for this holder in this stock.